CORRESP 1 filename1.htm

InflaRx N.V.

Winzerlaer Str. 2

07745 Jena, Germany

 

May 2, 2018



 

Division of Corporation Finance
U.S. Securities and Exchange Commission 

100 F Street, N.E.
Washington, D.C. 20549-3628 

Attn: Ms. Ada D. Sarmento
Ms. Erin Jaskot

 


 

Re: InflaRx N.V.
Registration Statement on Form F-1
Registration No. 333-224596

 

 

Dear Ms. Sarmento and Ms. Jaskot:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Daylight Time on May 3, 2018 or as soon thereafter as is practicable. By separate letter, the underwriters of the issuance of the securities being registered join in this request for acceleration.

 

Please do not hesitate to contact Sophia Hudson of Davis Polk & Wardwell LLP at (212) 450-4762 with any questions or comments with respect to this letter.

 

[Signature Page Follows]

 

 

 

 

Sincerely,

 

 

INFLARX N.V.
 
 
By: /s/ Niels Riedemann
  Name: Niels Riedemann
  Title: Chief Executive Officer

 

 

Via EDGAR

 

CC: Sophia Hudson, Davis Polk & Wardwell LLP